Company news
Kowa Co. Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
K-679: A Novel Antibody Drug-loaded Unimicelle Conjugate Demonstrates Tumor-Selective Pharmacokinetics, Extensive Intratumoral Distribution and Superior Efficacy in Non-Clinical Animal Models
April 6, 2026
KKR and Taiyo Holdings Agree to Privatization to Accelerate Long-Term Growth
March 31, 2026
Nicox and Kowa Sign Key Agreement worth up to €191.5 million for Exclusive Rights to Glaucoma Treatment NCX 470 in U.S. and all Unlicensed Territories
July 17, 2025